Novartis Looks To Kisqali To Lead Growth, Calls On Trump To Fix The IRA

The Swiss firm enjoyed an exceptional 12% sales growth last year, and believes it can compensate for the imminent loss of blockbuster Entresto with new products. CEO Vas Narasimhan also laid out his three-point wish list for the new US administration.